CORE
šŗš¦Ā
Ā make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis
Authors
A Desjardins
A Sandler
+45Ā more
AD Norden
AF Sher
AM Omuro
AM Omuro
CS Brock
ET Wong
F Bokstein
F Winkler
FB Furnari
H Hauch
HS Friedman
HS Friedman
HS Poulsen
IH Lee
J Dietrich
JE Wolff
JJ Vredenburgh
JJ Vredenburgh
JJ Vredenburgh
Johannes EA Wolff
Juxiang Chen
KV Ballman
LB Saltz
MD Prados
PY Wen
R Stupp
RK Jain
RK Jain
RM Zuniga
RT Tong
S Guiu
S Hapani
S Sathornsumetee
SA Ali
SB Wedam
SG Thompson
SR Nalluri
Tao Xu
TF Cloughesy
TN Kreisl
TY Kang
V Vallejos
W Chen
WK Yung
Yicheng Lu
Publication date
1 January 2010
Publisher
BioMed Central
Doi
Cite
View
on
PubMed
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 01/04/2019
Springer - Publisher Connector
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 03/05/2017
Springer - Publisher Connector
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 05/06/2019